EPRX

Eupraxia Pharmaceuticals
EPRX

Overview Fund Activity

8 hedge funds and large institutions have $4.43M invested in Eupraxia Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
+8
Holders Change %
–
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SC
Scotia Capital
Ontario, Canada
$3.5M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
$686K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
$133K
4
UBS Group
UBS Group
Switzerland
$76.3K
5
1WA
180 Wealth Advisors
Washington
$34.1K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
SC
1
Scotia Capital
Ontario, Canada
$3.5M +$3.5M +1,367,051 New
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$686K +$686K +265,744 New
Bank of Montreal
3
Bank of Montreal
Ontario, Canada
$133K +$133K +49,250 New
UBS Group
4
UBS Group
Switzerland
$76.3K +$76.3K +29,590 New
1WA
5
180 Wealth Advisors
Washington
$34.1K +$34.1K +13,000 New
JPMorgan Chase & Co
6
JPMorgan Chase & Co
New York
$4.88K +$4.88K +1,892 New
FDCDDQ
7
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.39K +$1.39K +545 New
Toronto Dominion Bank
8
Toronto Dominion Bank
Ontario, Canada
$304 +$304 +118 New